The FDA has cleared Sapience Therapeutics to begin clinical development [...]

AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

The European Commission has granted orphan drug designation to Chiesi [...]

Mabion has signed a letter of intent with French technology [...]

FDA has granted orphan drug designation to Tris Pharma’s investigational [...]

As Rare Disease Day 2026 shines a spotlight on patients [...]

Cereno Scientific has completed the last patient’s last visit in [...]

Kedrion has received orphan drug designation from the European Medicines [...]

Minovia Therapeutics has received orphan drug designation from the US [...]

Barcelona-based biotech advances Huntington’s programme as EMA backs orphan designation, [...]